503 related articles for article (PubMed ID: 36856980)
1. Dry Eye Disease Associated with Meibomian Gland Dysfunction: Focus on Tear Film Characteristics and the Therapeutic Landscape.
Sheppard JD; Nichols KK
Ophthalmol Ther; 2023 Jun; 12(3):1397-1418. PubMed ID: 36856980
[TBL] [Abstract][Full Text] [Related]
2. Perfluorohexyloctane Ophthalmic Solution: A Review in Dry Eye Disease.
Zhuang-Yan A; Syed YY
Drugs; 2024 Apr; 84(4):441-448. PubMed ID: 38554243
[TBL] [Abstract][Full Text] [Related]
3. Addressing excessive evaporation: an unmet need in dry eye disease.
Karpecki PM; Nichols KK; Sheppard JD
Am J Manag Care; 2023 Oct; 29(13 Suppl):S239-S247. PubMed ID: 37844320
[TBL] [Abstract][Full Text] [Related]
4. LipiFlow for the treatment of dry eye disease.
Pucker AD; Yim TW; Rueff E; Ngo W; Tichenor AA; Conto JE
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD015448. PubMed ID: 38314898
[TBL] [Abstract][Full Text] [Related]
5. A review of the first anti-evaporative prescription treatment for dry eye disease: perfluorohexyloctane ophthalmic solution.
Sheppard JD; Evans DG; Protzko EE
Am J Manag Care; 2023 Nov; 29(14 Suppl):S251-S259. PubMed ID: 37930231
[TBL] [Abstract][Full Text] [Related]
6. Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction.
Cote S; Zhang AC; Ahmadzai V; Maleken A; Li C; Oppedisano J; Nair K; Busija L; Downie LE
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013559. PubMed ID: 32182637
[TBL] [Abstract][Full Text] [Related]
7. Perfluorohexyloctane Eye Drops for Dry Eye Disease Associated With Meibomian Gland Dysfunction in Chinese Patients: A Randomized Clinical Trial.
Tian L; Gao Z; Zhu L; Shi X; Zhao S; Gu H; Xu G; Wang L; Dai H; Zhang H; Jin X; Ma K; Xu Y; Ma L; Pei C; Ke B; Krösser S; Zhang Y; Jie Y
JAMA Ophthalmol; 2023 Apr; 141(4):385-392. PubMed ID: 36929413
[TBL] [Abstract][Full Text] [Related]
8. NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction: Results of the Randomized Phase 3 GOBI Study.
Tauber J; Berdy GJ; Wirta DL; Krösser S; Vittitow JL;
Ophthalmology; 2023 May; 130(5):516-524. PubMed ID: 36574848
[TBL] [Abstract][Full Text] [Related]
9. Evaporative dry eye disease due to meibomian gland dysfunction: Preferred practice pattern guidelines for diagnosis and treatment.
Narang P; Donthineni PR; D'Souza S; Basu S
Indian J Ophthalmol; 2023 Apr; 71(4):1348-1356. PubMed ID: 37026266
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, Severity, and Treatment Outcomes of Meibomian Gland Dysfunction in Patients With Dry Eye Symptoms at a Tertiary Care Center in South India.
Singh J; Priya Y; Bhat V
Cureus; 2022 Jun; 14(6):e25703. PubMed ID: 35812580
[TBL] [Abstract][Full Text] [Related]
11. Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction.
Baudouin C; Messmer EM; Aragona P; Geerling G; Akova YA; Benítez-del-Castillo J; Boboridis KG; Merayo-Lloves J; Rolando M; Labetoulle M
Br J Ophthalmol; 2016 Mar; 100(3):300-6. PubMed ID: 26781133
[TBL] [Abstract][Full Text] [Related]
12. Effect of thermal pulsation treatment on tear film parameters in dry eye disease patients.
Kim MJ; Stinnett SS; Gupta PK
Clin Ophthalmol; 2017; 11():883-886. PubMed ID: 28533678
[TBL] [Abstract][Full Text] [Related]
13. Eyelid Warming Devices: Safety, Efficacy, and Place in Therapy.
Bzovey B; Ngo W
Clin Optom (Auckl); 2022; 14():133-147. PubMed ID: 35959466
[TBL] [Abstract][Full Text] [Related]
14. Emerging strategies for the diagnosis and treatment of meibomian gland dysfunction: Proceedings of the OCEAN group meeting.
Geerling G; Baudouin C; Aragona P; Rolando M; Boboridis KG; Benítez-Del-Castillo JM; Akova YA; Merayo-Lloves J; Labetoulle M; Steinhoff M; Messmer EM
Ocul Surf; 2017 Apr; 15(2):179-192. PubMed ID: 28132878
[TBL] [Abstract][Full Text] [Related]
15. Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease.
Steven P; Augustin AJ; Geerling G; Kaercher T; Kretz F; Kunert K; Menzel-Severing J; Schrage N; Schrems W; Krösser S; Beckert M; Messmer EM
J Ocul Pharmacol Ther; 2017 Nov; 33(9):678-685. PubMed ID: 28922088
[TBL] [Abstract][Full Text] [Related]
16. NOV03 for Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction: The Randomized Phase 3 MOJAVE Study.
Sheppard JD; Kurata F; Epitropoulos AT; Krösser S; Vittitow JL;
Am J Ophthalmol; 2023 Aug; 252():265-274. PubMed ID: 36948372
[TBL] [Abstract][Full Text] [Related]
17. Lipid layer thickness decrease due to meibomian gland dysfunction leads to tear film instability and reflex tear secretion.
Kim WJ; Ahn YJ; Kim MH; Kim HS; Kim MS; Kim EC
Ann Med; 2022 Dec; 54(1):893-899. PubMed ID: 35379048
[TBL] [Abstract][Full Text] [Related]
18. Image-based quantitative analysis of tear film lipid layer thickness for meibomian gland evaluation.
Hwang H; Jeon HJ; Yow KC; Hwang HS; Chung E
Biomed Eng Online; 2017 Nov; 16(1):135. PubMed ID: 29169367
[TBL] [Abstract][Full Text] [Related]
19. Differential characteristics among asymptomatic and symptomatic meibomian gland dysfunction and those with dry eye.
Chiou YR; Lin PY; Chou YB; Huang PW; Fan NW
BMC Ophthalmol; 2023 Apr; 23(1):154. PubMed ID: 37041510
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
